Lv1
20 积分 2024-01-17 加入
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
8个月前
已完结
不同年龄多发性骨折患者血小板参数和凝血指标的时相改变
10个月前
已完结
Effect of DMARDs on the immunogenicity of vaccines
1年前
已完结
皖公网安备34019202002308
